Allan Ma, Bruce Motyka, Klaus Gutfreund, Yuenian Eric Shi, & Rajan George. (2020). A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Taylor & Francis Group.
Chicago Style (17th ed.) CitationAllan Ma, Bruce Motyka, Klaus Gutfreund, Yuenian Eric Shi, and Rajan George. A Dendritic Cell Receptor-targeted Chimeric Immunotherapeutic Protein (C-HBV) for the Treatment of Chronic Hepatitis B. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationAllan Ma, et al. A Dendritic Cell Receptor-targeted Chimeric Immunotherapeutic Protein (C-HBV) for the Treatment of Chronic Hepatitis B. Taylor & Francis Group, 2020.
Warning: These citations may not always be 100% accurate.